➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Baxter
Boehringer Ingelheim
Mallinckrodt
Dow

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Litigation Details for Image Processing Technologies, LLC v. Samsung Electronics Co., Ltd. (E.D. Tex. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Image Processing Technologies, LLC v. Samsung Electronics Co., Ltd. (E.D. Tex. 2020)

Docket   Start Trial Date Filed 2020-02-24
Court District Court, E.D. Texas Date Terminated
Cause 35:271 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand None Referred To Roy S. Payne
Patents 10,004,792; 10,076,526; 10,441,505; 10,441,596; 10,526,594; 10,596,276; 7,195,757; 7,579,189; 7,872,050; 8,003,792; 8,003,853; 8,080,526; 8,269,019; 8,269,150; 8,802,137; 8,802,702; 8,853,269; 9,029,356; 9,441,047; 9,802,094
Link to Docket External link to docket
Small Molecule Drugs cited in Image Processing Technologies, LLC v. Samsung Electronics Co., Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Image Processing Technologies, LLC v. Samsung Electronics Co., Ltd.

Details for Image Processing Technologies, LLC v. Samsung Electronics Co., Ltd. (E.D. Tex. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-05-14 123 Memorandum & Opinion 2 of 8 PageID #: 10929 00505-JRG, Dkt. No. 356 at 1-2. The present case is severed from the Prior…Partes Review (“IPR”) involving the asserted patents. Image Processing Technologies, LLC v. Samsung …Samsung to its Alleged Use of the Asserted Patents, Dr. Stevenson states he “will discuss the technical…February 2020 2:20-cv-00050-JRG-RSP Patent None District Court, E.D. Texas … serve their supplemental damages report by April 29, 2020. Dkt. No. 62 at 2. Furthermore, Samsung External link to document
2020-05-14 124 Memorandum & Opinion incremental benefits. Id. at 9-10. Samsung continues by noting that patent damages opinions must “reflect…/14/20 Page 10 of 12 PageID #: 10945 Asserted Patents is a minor …valuations of use of the patents in infringing features. Dkt. No. 26-16 at 4. However, Samsung has not…other grounds by Williamson v. Citrix Online, LLC, 792 F.3d 1339 (Fed. Cir. 2015) (en banc). “Vigorous…Partes Review (“IPR”) involving the asserted patents. Image Processing Technologies, LLC v. Samsung External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
Mallinckrodt
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.